Jeff Auxier’s MDT Holdings & Trades

First Buy
Q1 2015
Duration Held
43 Quarters
Largest Add
Q1 2015
+140,083 Shares
Current Position
139,988 Shares
$13.33 M Value

Jeff Auxier's MDT Position Overview

Jeff Auxier (via Auxier Asset Management LLC) currently holds 139,988 shares of Medtronic plc (MDT) worth $13.33 M, representing 1.87% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 43 quarters.

Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2016, adding 7,800 shares. Largest reduction occurred in Q4 2018, reducing 6,040 shares.

Analysis based on 13F filings available since 2013 Q2

Jeff Auxier's Medtronic plc (MDT) Holding Value Over Time

Track share changes against reported price movement

Quarterly Medtronic plc (MDT) Trades by Jeff Auxier

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2015 +140,083 New Buy 140,083 $77.99
Q2 2015 -500 Reduce 0.36% 139,583 $74.10
Q3 2015 -110 Reduce 0.08% 139,473 $66.94
Q4 2015 -200 Reduce 0.14% 139,273 $76.92
Q1 2016 +500 Add 0.36% 139,773 $75.00
Q2 2016 -600 Reduce 0.43% 139,173 $86.77
Q3 2016 -50 Reduce 0.04% 139,123 $86.40
Q4 2016 +7,800 Add 5.61% 146,923 $71.23
Q1 2017 +100 Add 0.07% 147,023 $80.56
Q2 2017 -25 Reduce 0.02% 146,998 $88.75
Q3 2017 +1,250 Add 0.85% 148,248 $77.77
Q4 2017 +7,085 Add 4.78% 155,333 $80.75
Q1 2018 +5,915 Add 3.81% 161,248 $80.22
Q2 2018 -2,150 Reduce 1.33% 159,098 $85.61
Q3 2018 -1,900 Reduce 1.19% 157,198 $98.37
Q4 2018 -6,040 Reduce 3.84% 151,158 $90.96
Q1 2019 -285 Reduce 0.19% 150,873 $91.08
Q2 2019 -2,325 Reduce 1.54% 148,548 $97.39
Q3 2019 -3,645 Reduce 2.45% 144,903 $108.62
Q4 2019 -185 Reduce 0.13% 144,718 $113.45
Q1 2020 -413 Reduce 0.29% 144,305 $90.18
Q2 2020 -225 Reduce 0.16% 144,080 $91.70
Q3 2020 -65 Reduce 0.05% 144,015 $103.92
Q4 2020 -133 Reduce 0.09% 143,882 $117.14
Q1 2021 -300 Reduce 0.21% 143,582 $118.13
Q2 2021 -1,645 Reduce 1.15% 141,937 $124.13
Q3 2021 -915 Reduce 0.64% 141,022 $125.35
Q4 2021 -185 Reduce 0.13% 140,837 $103.45
Q1 2022 -5 Reduce 0.00% 140,832 $110.95
Q2 2022 +2,575 Add 1.83% 143,407 $89.75
Q3 2022 -300 Reduce 0.21% 143,107 $80.75
Q4 2022 +1,900 Add 1.33% 145,007 $77.72
Q1 2023 +2,075 Add 1.43% 147,082 $80.62
Q2 2023 +285 Add 0.19% 147,367 $88.10
Q3 2023 -125 Reduce 0.08% 147,242 $78.36
Q4 2023 -255 Reduce 0.17% 146,987 $82.38
Q1 2024 +153 Add 0.10% 147,140 $87.15
Q2 2024 -3,598 Reduce 2.45% 143,542 $78.71
Q3 2024 -110 Reduce 0.08% 143,432 $90.03
Q4 2024 -2,190 Reduce 1.53% 141,242 $79.88
Q1 2025 -98 Reduce 0.07% 141,144 $89.86
Q2 2025 -558 Reduce 0.40% 140,586 $87.17
Q3 2025 -598 Reduce 0.43% 139,988 $95.24

Jeff Auxier's Medtronic plc Investment FAQs

Jeff Auxier first purchased Medtronic plc (MDT) in Q1 2015, acquiring 140,083 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeff Auxier has held Medtronic plc (MDT) for 43 quarters since Q1 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeff Auxier's largest addition to Medtronic plc (MDT) was in Q1 2015, adding 140,083 shares worth $10.92 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 139,988 shares of Medtronic plc (MDT), valued at approximately $13.33 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Medtronic plc (MDT) represents approximately 1.87% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jeff Auxier's peak holding in Medtronic plc (MDT) was 161,248 shares, as reported at the end of Q1 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.